Loxo Oncology Stock Return On Asset
Loxo Oncology fundamentals help investors to digest information that contributes to Loxo Oncology's financial success or failures. It also enables traders to predict the movement of Loxo Stock. The fundamental analysis module provides a way to measure Loxo Oncology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Loxo Oncology stock.
Loxo |
Loxo Oncology Company Return On Asset Analysis
Loxo Oncology's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Loxo Oncology Return On Asset | -0.0059 |
Most of Loxo Oncology's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Loxo Oncology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Loxo Oncology has a Return On Asset of -0.0059. This is 99.93% lower than that of the Healthcare sector and 99.97% lower than that of the Biotechnology industry. The return on asset for all United States stocks is 95.79% lower than that of the firm.
Loxo Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Loxo Oncology's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Loxo Oncology could also be used in its relative valuation, which is a method of valuing Loxo Oncology by comparing valuation metrics of similar companies.Loxo Oncology is currently under evaluation in return on asset category among related companies.
Loxo Fundamentals
Return On Equity | -0.63 | |||
Return On Asset | -0.0059 | |||
Profit Margin | (43.49) % | |||
Operating Margin | (50.33) % | |||
Current Valuation | 6.56 B | |||
Shares Outstanding | 30.75 M | |||
Shares Owned By Insiders | 3.70 % | |||
Shares Owned By Institutions | 92.93 % | |||
Number Of Shares Shorted | 1.03 M | |||
Price To Earning | (20.33) X | |||
Price To Book | 18.92 X | |||
Price To Sales | 49.84 X | |||
Revenue | 144.8 M | |||
Gross Profit | (118.74 M) | |||
EBITDA | (147.98 M) | |||
Net Income | (62.98 M) | |||
Cash And Equivalents | 622 M | |||
Cash Per Share | 3.71 X | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 3.62 X | |||
Book Value Per Share | 12.50 X | |||
Cash Flow From Operations | 234.3 M | |||
Short Ratio | 0.50 X | |||
Earnings Per Share | (2.09) X | |||
Price To Earnings To Growth | (2.75) X | |||
Number Of Employees | 59 | |||
Beta | 2.97 | |||
Market Capitalization | 7.22 B | |||
Total Asset | 157.46 M | |||
Retained Earnings | (82.93 M) | |||
Working Capital | 153.79 M | |||
Current Asset | 156.64 M | |||
Current Liabilities | 2.85 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Loxo Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Loxo Oncology's short interest history, or implied volatility extrapolated from Loxo Oncology options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Loxo Stock
If you are still planning to invest in Loxo Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Loxo Oncology's history and understand the potential risks before investing.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies |